Merck & Co pens $340m pain drug deal with KCL and Wellcome
Summary Merck & Co has announced a deal with King’s College London (KCL) and Wellcome to investigate a new class of painkillers…
Summary Merck & Co has announced a deal with King’s College London (KCL) and Wellcome to investigate a new class of painkillers…
Summary : Alembic Pharmaceuticals received a tentative approval from the United States Food & Drug Administration (USFDA) for its Abbreviated New Drug…
Synopsis : Nirsevimab has the potential to offer RSV protection for all infants, with a single dose showing 74.5 percent efficacy in…
Summary : OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE), today announced that early biomarker analyses from the ongoing Phase 1 clinical trial with SIRPα…
Summary : Pfizer Inc. (plaintiff) filed a patent infringement suit against West-Coast Pharmaceutical works Ltd. (defendant) for inviting manufacturers to contract with…
Summary : PE firm Carlyle-backed SeQuent Scientific has acquired 100% stake in Brazil-based Nourrie Sade e Nutrio Animal Ltd for $5mn (Rs36.2cr),…
Summary : AbbVie has bolstered its neuropsychiatric and neurodegenerative portfolio with the acquisition of Belgium-based Syndesi Therapeutics in a deal valued at…
Summary : NICE has issued a positive recommendation for Arvelle Therapeutics’ cenobamate (Ontozry), for the treatment of focal-onset seizures in adults with…
Summary : GC Pharma (KRX:006280) today announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug…
Summary : Chicago-based AbbVie has been making major decisions with company-wide impacts. The therapeutic company appears to be making changes that will…